Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» non-small cell lung cancer
non-small cell lung cancer
Roche's Tarceva Progresses in Japan
Yahoo/Zacks
Tue, 06/18/13 - 08:59 am
Japan
Roche
Tarceva
non-small cell lung cancer
Clovis / CO-1686: Value, Derived From Data, Supports The Valuation
Seeking Alpha
Wed, 06/12/13 - 09:07 am
CO-1686
Clovis Oncology
non-small cell lung cancer
Synta Pharmaceuticals: A Promising Biotech Stock for 2013
Motley Fool
Tue, 06/4/13 - 11:13 am
Synta Pharmaceuticals
ganetespib
non-small cell lung cancer
NewLink Genetics Presents Positive Phase 2 Data on Novel Immunotherapy, Tergenpumatucel-L, in Non-Small Cell Lung Cancer at the ASCO 2013 Annual Meeting
Yahoo/PR Newswire
Sat, 06/1/13 - 12:19 pm
NewLink Genetics
tergenpumatucel-L
non-small cell lung cancer
Encouraging News for Peregrine Pharma
Yahoo/Zacks
Sat, 05/25/13 - 11:34 am
Peregrine Pharmaceuticals
bavituximab
non-small cell lung cancer
lung cancer
AstraZeneca Advances Three Cancer Drugs Into Late-Stage Trials
Bloomberg
Thu, 05/16/13 - 10:33 am
AstraZeneca
moxetumomab pasudotox
hairy cell leukemia
olaparib
ovarian cancer
selumetinib
non-small cell lung cancer
Bristol-Myers Has The Future Of Oncology Therapies
Seeking Alpha
Sun, 05/5/13 - 11:00 am
Bristol-Myers Squibb
nivolumab
BMS-936558
non-small cell lung cancer
renal cell carcinoma
melanoma
Ono Pharmaceutical
tivozanib
Aveo Pharmaceuticals
elotuzumab
Array's Up-Coming Value Enhancing Catalysts
Seeking Alpha
Wed, 04/17/13 - 10:50 am
Array Biopharma
Amgen
Novartis
AstraZeneca
selumetinib
MEK162
melanoma
non-small cell lung cancer
ImmunoGen Offers New Hope For Treatment Of Subtypes Of Squamous Cell Carcinomas And Other Cancers
Seeking Alpha
Sun, 04/14/13 - 12:16 pm
non-small cell lung cancer
Immunogen
IMGN289
head and neck cancer
ARIAD presents new preclinical data on ponatinib
The Fly on the Wall
Mon, 04/8/13 - 11:38 am
Ariad Pharmaceuticals
Ponatinib
medullary thyroid cancer
non-small cell lung cancer
Merrimack lung cancer drug fails goal in one mid-stage trial group
Reuters
Thu, 04/4/13 - 09:22 am
lung cancer
Merrimack Pharmaceuticals
MM-121
non-small cell lung cancer
FDA seeks to fast track Novartis lung cancer drug
Reuters
Fri, 03/15/13 - 11:10 am
FDA
fast track
Novartis
non-small cell lung cancer
LDK378
FDA fast tracks two new lung cancer drugs
PM Live
Fri, 01/18/13 - 10:17 am
fast track
FDA
Boehringer Ingelheim
Astellas
Roche
Afatinib
Tarceva
non-small cell lung cancer
BI's cancer drug afatinib gets US fast-track review
Pharma Times, UK
Wed, 01/16/13 - 08:38 am
Afatinib
Boehringer Ingelheim
fast track
non-small cell lung cancer
Peregrine Recovers As Phase II Trial Is Salvaged
Seeking Alpha
Wed, 01/9/13 - 09:31 am
Peregrine Pharmaceuticals
bavituximab
non-small cell lung cancer
FDA designates GTx's enobosarm as Fast Track development program
Yahoo/Fly on the Wall
Tue, 01/8/13 - 10:38 am
FDA
GTx
enobosarm
fast track
non-small cell lung cancer
Pfizer lung cancer drug gets conditional EU approval
Reuters
Wed, 10/24/12 - 11:42 am
Pfizer
Europe
non-small cell lung cancer
Xalkori
FDA Label Expansion for Abraxane
Yahoo/Zacks
Tue, 10/23/12 - 04:21 pm
FDA
Abraxane
non-small cell lung cancer
Celgene
ArQule's Tivantinib Failure And Exelixis' Cabozantinib PDUFA: Is There A Correlation?
Seeking Alpha
Fri, 10/12/12 - 12:17 pm
Arqule
tivantinib
Exelixis
cabozantinib
non-small cell lung cancer
ArQule stock plunges as lung cancer study shelved
Yahoo/AP
Tue, 10/2/12 - 11:25 am
Arqule
lung cancer
Daiichi Sankyo
tivantinib
non-small cell lung cancer
Pages
« first
‹ previous
…
15
16
17
18
19
20
21
22
23
next ›
last »